In a seminal March 2021 New England Journal of Medicine study, adults receiving a weekly 2.4 mg injection of semaglutide for about 15 months lost 15% of their body weight35 pounds, on averagecompared to just 2.4% body weight loss in the placebo group
Safe and Sterile: Each needle is individually sealed, sterilized using gamma radiation, and made with non-toxic, non-pyrogenic materials, ensuring a secure and hygienic injection experience
Nonetheless, some commercial mimics of GLP-1, such as Liraglutide, even when administered peripherally, appear to cross the BBB and activate neurons within the ARC resulting in GABA dependent inhibition of neuropeptide Y (NPY) and agouti-related peptide (AgRP) secretion
This is particularly significant, as we know that these drugs affect the brain, which is likely beneficial
Most patients experience significant weight loss and can lose 5-10% of their body weight over the course of 6 months with weekly injections
Behavioral compensations and neuronal remodeling in a rodent model of chronic intervertebral disc degeneration
